Coronavirus India Latest Updates: Active Cases Decline To 1.42 Lakh, Cadila To Supply One Crore Vaccines
India's active caseload continued to decline as daily recoveries exceeded fresh cases for the third day in a row.
India added 11,451 fresh cases in the last 24 hours, with the tally rising above to 3.43 crore in the world’s second-most populous country, according to the Health Ministry’s update as of 8 a.m. on Nov. 8. That compares with 13,204 recoveries made in the same period.
Active cases fell further to 1.42 lakh, and now make up 0.42% of India's total tally, the lowest since March 2020.
Total confirmed cases: 3,43,66,987
Total number of active cases: 1,42,826
Total patients cured/discharged/migrated: 3,37,63,104
Total deaths: 4,61,057
Number of fresh cases in last 24 hours: 11,451
One-day recoveries: 13,204
One-day deaths: 266
Vaccines administered in the last 24 hours: 23,84,096
Total vaccines given: 1,08,47,23,042
Cadila To Supply One Crore Vaccine Doses To Centre
Cadila Healthcare Ltd. has received an order to supply one crore doses of its three-dose intradermal plasmid DNA vaccine to the Government of India. This makes it the fourth vaccine to be approved for use in India after Serum Institute’s Covishield, Bharat Biotech’s Covaxin and the Russian Covid-19 vaccine-Sputnik.
ZyCov-D, the world’s first plasmid DNA vaccine which comes with a needle-free applicator has been priced at Rs 265 per dose while the applicator would be offered at Rs 93 per dose. This price is excluding GST. The vaccine has a primary established efficacy of 66.66% for the symptomatic RT-PCR positive cases and the jab has been found safe for children in the age group of 12-18 years.